- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2011
- Public Summary Document (PSD) November 2011 PBAC Meeting - PDF
Tenofovir with emtricitabine and rilpivirine – November 2011
Tenofovir with emtricitabine and rilpivirine, tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and rilpivirine hydrochloride 25 mg, Eviplera® - November 2011
Last updated
2 March 2012